Company News 20 Oct 2025 Orthocell secures global distribution rights to innovative bone regeneration technology Orthocell has signed Memorandum of Understanding to increase its equity stake in Marine Biomedical - from 1.7% to 12.0% for… Orthocell
Company News 17 Oct 2025 $30.0 Million Placement to Accelerate Global Commercialisation and Advance Product Portfolio Orthocell has today announced that it has received firm commitments for a $30 million capital raising via an institutional placement. Orthocell
Company News 10 Oct 2025 Quarterly Report – period ended 30 September 2025 Orthocell has today released its Quarterly Report for the period ended 30 September 2025, outlining a period of continued growth… Orthocell
Company News 02 Oct 2025 Orthocell Announces Record Revenue of $3m for September Quarter Orthocell has announced record quarterly revenue of $3.0 million for the September quarter – our sixth consecutive quarter of record… Orthocell
Company News 30 Sep 2025 Orthocell Appoints First Distributor for Remplirâ„¢ in US$75m Canadian Market Orthocell has appointed its first Canadian distributor for Remplirâ„¢, signalling the commencement of the Company’s commercial roll out in the… Orthocell
Company News 16 Sep 2025 Global opportunity emerges as Remplirâ„¢ is used in nerve-sparing prostate cancer surgery Orthocell has identified a promising new application for its flagship Remplirâ„¢ nerve repair device - for use in nerve-sparing Robotic-Assisted… Orthocell
Company News 08 Sep 2025 Remplirâ„¢ Real World Evidence study delivers compelling 81% success rate Orthocell has today released interim results from a new Remplirâ„¢ Real World Evidence study, demonstrating an overall treatment success rate… Orthocell
Company News 13 Aug 2025 Commercialisation of Remplirâ„¢ into US Market Continues to Build Momentum Orthocell has today provided update on the continuing successful commercialisation of its flagship nerve repair product Remplirâ„¢ in the US. Orthocell
Company News 25 Jul 2025 Orthocell Announces Changes to its Board of Directors Orthocell has today announced some important changes to its Board of Directors. Orthocell
Company News 10 Jul 2025 First US Sales Revenue from Remplirâ„¢ Orthocell has today reached a critical milestone in the commercialisation of Remplirâ„¢ in the US$1.6 Billion US market, recording its… Orthocell
